/
HHBT
$0.00-$0.00 (-50.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | |
|---|---|
| Revenue | $8.0M |
| Cost of revenue | $5.6M |
| Gross profit | $2.4M |
| Gross margin | 29.5% |
| R&D | $0 |
| Operating income | $3.1M |
| EBITDA | $5.4M |
| Net income | $2.5M |
| Net margin | 31.0% |
| EPS (diluted) | 0.18 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$2.74
Price
$0.00
Implied upside
+2737800%
Peer comparison
HH BIOTECHNOLOGY HOLDINGS
HH BIOTECHNOLOGY HOLDINGS
Held by traders on TradeandTell
No one on the platform currently holds HHBT.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HHBT as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HHBT yet.